Discover open access scientific publications

Search, annotate, share and cite publications

Publications by N. Tageja

A Phase II Trial of Pan-Kir2d Blockade With IPH2101 in Smoldering Multiple Myeloma

English

Related publications

Checkpoint Inhibition of KIR2D With the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients With Myeloma

Clinical Cancer Research

Cancer Research

English

A Phase I Trial of Flavopiridol in Relapsed Multiple Myeloma

Cancer Chemotherapy and Pharmacology

Cancer Research

English

The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective

Cancer Research

English

Phase I/Ii Trial of Bendamustine, Ixazomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Blood Cancer Journal

English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Hematology/Oncology Clinics of North America

English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Current Hematologic Malignancy Reports

Cancer Research

English

Smoldering Multiple Myeloma: Prevalence and Current Evidence Guiding Treatment Decisions

Blood and Lymphatic Cancer: Targets and Therapy

English

Case Study: An Unusual Presentation of Smoldering Multiple Myeloma in a Patient With End Stage Renal Disease

American Society for Clinical Laboratory Science

English

Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib

Blood Cancer Journal

English